Expects to have 22 states onboard in near future, preventing 'doctor shopping' and other abuses
Prescription drug monitoring programs (PDMPs, also known as PMPs) enable pharmacists to share prescription-fulfillment data to prevent “doctor shopping” by abusers of, among other drugs, opioids. By sharing the data, pharmacists can be aware when a patient has filled one prescription recently for the controlled substance, which should prevent others from being filled. Most states (41 at last count) have a PMP in place, and more are joining. But the ability of abusers to cross state lines has meant that a national PMP is necessary.
The National Assn. of Boards of Pharmacy (NABP; Mt. Prospect, IL) has stepped into this breach with the NABP InterConnect program, which enables the interstate sharing to occur. Nine states (AZ, CT, IN, KS, MI, ND, OH, SC and VA) have already linked in, and an additional dozen or so states are expected in the near future, according to NABP. Pharmacists can obtain a report in less than eight seconds from the system, says the group, and to date, some 375,000 reports have been generated. Furthermore, NABP says that it has absorbed all the costs of setting up and administering the program, and is committed to doing so for the next five years. There are federal dollars available, through a variety of programs, for states to run their PMPs.
PMPs parallel, but do not replace, the efforts made by wholesalers to the Drug Enforcement Administration, under the Controlled Substances Act, to regulate the distribution of DEA-regulated drugs. Under DEA oversight, wholesalers and retail pharmacies are obligated to report the quantities of controlled substances they are ordering, dispensing or otherwise distributing.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.